MUNICIPAL CORPORATION OF

DELHI TENDER ENQUIRY FORM

FOR

BIENNIAL RATE CONTRACT 2010-11-12

(PROPRIETORY/PANCHKARMA\ AND CLASSICAL AYURVEDIC MEDICINES) Contents: - Tender Document with Annexure, Terms & Conditions, Agreement and Drug Schedule.

Office of Deputy Health Officer (Ayurveda) Health Department Municipal Corporation of Delhi.

Page 2 of 48

Contents Sl. No. Topic Page No. 1. Tender Form 2. Terms and conditions of NIT 3. Annexure 4. Inventory of Drugs Group wise 5. Schedule of Events

Page 3 of 48

MUNICIPAL CORPORATION OF DELHI (HEALTH DEPARTMENT)

Rate Schedule

SR No……….. MCD TENDER NO………………… Group…………… TENDER FOR THE SUPPLIES OF PROPRIETORY/PANCHKARMA & CLASSICAL AYURVEDIC MEDICINES FOR THE YEAR 2010 –11-12 The financial bid is to be uploaded in the concerned template.

Page 4 of 48

MUNICIPAL CORPORATION OF DELHI (HEALTH DEPARTMENT)

TENDER ENQUIRY Under the policy approved by the Standing Committee vide Resolution No. I94 dated

24.8.98, further amended vide Corporation Resolution 1022 Dated 16-2-2009 , tenders are invited from those firms which are having valid Drug Manufacturing License for fixing the rate contract and agency on biennial basis for the supply of Ayurvedic Medicines to the institutions under Municipal Corporation of Delhi for year 2010-11-12 on the following terms and conditions:

The entire process of tendering will be done through e-tendering. Prescribed tender forms along with terms and conditions can be downloaded from website of M.C.D i.e http://mcdetenders.com. Firms desirous of participating shall have to deposit Rs.500/- in the form of Demand Draft in favor of Commissioner, MCD along with techno-commercial-bid.

All interested firms are required to have Digital Certificate for participating in the tender. Those who do not have Digital Certificate shall have to obtain D.C. from office of M/s Wipro Ltd./Tender Home at Ambedkar Stadium. Tenders will be opened in the office of Accounts Officer (Health & Plan), Room No. 52, Town Hall, Delhi – 110006 as per schedule. The entire tender process will be as per standard e-tendering norms of MCD. Any other information regarding tender can be obtained from office of Dy.DHA (Ay)/ D.H.O. (ISM), Tel. No. 23866342. I. PURCHASE THROUGH OPEN E-TENDER Tenders will be accepted under two bid system i.e. Techno-Commercial Bid & Financial Bid. A) Techno-Commercial Bid. As a part of initiative in e-governance, MCD is introducing e-tendering in Health Department for the first time. Firms desirous of participating in e-tendering should have a valid Digital Certificate that is essential for participation. In case, any firm, desirous of participating in the tender, does not have valid D.C. they can apply in the office of Addl. M.H.O. (Medical) for registration & issuance of D.C. that will be issued by M/s Wipro Ltd./Tender

Home. The Techno-Commercial Bid shall include copies of a large number of documents viz. Earnest Money, PAN/ITCC, STCC/VAT, Registration with Govt. Agencies, Drug License, Test Analysis Report, etc. Therefore, in order to facilitate submission of tenders by the manufacturers, firms participating in tender shall submit the techno-commercial-bid along with copies of all essential documents etc. in the office of A.O. (H&P), Room No. 52, Town Hall, Delhi – 110 006 on or before the scheduled date. While they shall furnish the information in the template that the techno-commercial-bid submitted by them contains all necessary documents including EMD & Tender Fee. The details of documents to be submitted are given in the subsequent pages. The entire Techno-Commercial-Bid will be submitted in sealed envelope.

Page 5 of 48

Envelope-1 super scribed as ENVELOPE NO-1 Office of Dy. DHA (Ayurveda) formerly D.H.O. (Ayurveda) TECHNO-COMMERCIAL –BID TENDER FOR THE SUPPLY OF-------------------- Group…………….. TENDER NO------------Due on ----------------------- B) Financial Bid. The tenderers will be asked to submit technical bid and price bid in separate envelopes. The technical bid will be opened first and tenderers will be short listed on the basis of the pre-determined criteria and documents submitted in support thereof, listed hereinafter. The items of drugs quoted shall be approved or rejected on the basis of scrutiny of samples submitted with techno-commercial-bid by following various methods. The price bids of only short listed tenderers will be re-encrypted. Similarly the rates of samples of drugs approved by the purchase board shall only be re-encrypted. The rate contract will be made with the lowest bidders and if required negotiations can be made with eligible L-1 as per C.V.C. guidelines. Copies of the rate contract so finalized will be sent to all medical institutions under M.C.D who may place order on the rate contract holders for supply of drugs as per their requirement. Purchase preference shall be given to P.S.Us. like IMPCL & CCRAS over other rate contract holders. However, they shall have to participate in the tender process. ENVELOPE NO.1 (Details of documents & samples) A. Documents It will contain following documents in serial order:- 1. Earnest Money Deposit (E.M.D). Every tenderer will have to deposit an amount of Rs10,000/- (Rs. Ten thousand only) in the form of demand draft in favor of Commissioner, Municipal Corporation of Delhi. No cheque will be accepted and previous year’s earnest money will not be accepted. The requisite earnest money of Rs.10,000/- shall be payable by depositing Demand Draft in favour of Commissioner MCD along with techno-commercial-bid. 2. Forwarding letter as per prescribed Performa supplied by M.C.D (Annexure No.1). 3. Permanent Account Number (compulsory) and I.T.C.C. (Optional). 4. Sales Tax Clearance/VAT Clearance certificate of manufacturer for preceding 2

yrs. 5. Certified copy of "Drug manufacturing License” from Food & Drugs Administration along with the list of products licensed to manufacture, duly renewed up to date. If quoted items are being manufactured at different places, manufacturing license from respective F.D.A./Drug Controller should be enclosed. Tenderers should highlight the items quoted in the list of products licensed to manufacture and also mention the Sr. No. of the item as per inventory.

Page 6 of 48

6. Performance certificate from concerned Food & Drugs Administration in enclosed Performa (Annexure No. II). If the manufacturer is manufacturing the same items for which tender is filled in at various places either in Delhi or outside Delhi, he should obtain performance certificate from the respective Food & Drugs Administration authority where the manufacturing activities are carried out. Performance certificate should not be more than two years old and should clearly mention that the item quoted is being manufactured, at least, for last three years. 7. Certificate from concerned Food & Drugs Administration that the drugs licensed to be manufactured are manufactured by using Good Manufacturing Practice (latest copy of GMP to be enclosed).

8. Bonafide Distributor Certificate/Authority Letter – Annexure No. III. i. Tenders will be accepted from manufacturers only. Manufacturers desirous of participating in e-tendering should have valid Digital Certificate. However, manufacturing firm can appoint distributor (Area-wise) for supply or can supply directly. A manufacturing firm desirous of appointing distributor should mention their name. No change of distributor within the tender period will normally be allowed. Copy of Drug License of such distributor renewed up to date should be submitted along with authority letter of distributor as per Performa. ii. Authorized Distributor/Agent/Dealer should also submit his Sales Tax/VAT clearance certificate and Drugs License in Envelope No. 1. 9. Firms who wish to submit Tender Enquiry/Bid for drugs under all Group No. 1 – VII (Proprietary) should have an annual turnover of Rs. 100 lac or more for each year for preceding 3 years. A certificate to this effect be attached, from CA. Enclose copy of Audited balance sheet and income Tax Return and profit & loss account for the past three financial years in support of the claim.

10. Performa for Quality Control to be submitted as per Annexure – V. 11. Item-wise remarks, if any, worth mentioning regarding the product.

12. Any assumption condition, deviation etc. different than those stated in the tender invited and condition thereof has to be mentioned clearly.

13. Details of Tenderer as per Annexure No. VII will be submitted along with the tender 14. Statement showing installed capacity of the product quoted and quantity which tenderer will be able to supply in the event of selection should be submitted in envelope No. 1(Annexure. No. VIII).

15. Sample receipt. The original receipts of samples obtained from O.I.P.S., Nigam Bodh Ghat should be submitted alongwith Envelop- I in Annexure – IV.

16. Copy of test report, of each item quoted, from Govt. recognized Lab. in form ‘50’ as provided under the Drugs & Cosmetic Act 1940. Annexure-X.

17. A list of approved Ayurveda, Siddha & Unani Drug Testing Laboratories under Rule- 160A to J of the Drugs and Cosmetics Rule 1945 is available on the website of M.O.H.F.W., G.O.I. i.e. http://indianmedicine.nic.in/Drug-testing-facilities.asp

18. Wherever possible the firm should submit standard testing protocol for analysis of the drug as such or its constituents.

19. The definite storage conditions, if any, should be mentioned alongwith the supplies.

20. Past Performance: If there is failure to supply/part supply of any item for 3 or more occasions of a particular item during the existing period of Contract, the firm may be debarred to supply the said item. The firm should submit an undertaking to that effect.

Page 7 of 48

B. Samples The tenderer is required to submit one set of sample of drugs on or before specified date. The tenderer should fill in Performa receipt in triplicate for each item. The office of the OIPS, Nigam Bodh Ghat, Delhi on receiving the sample will issue receipt in duplicate to the tenderer. The tenderer should retain original with him. The duplicate copy should be enclosed in Envelope no. 1. (Annex. no IV). The tenderer should submit labeled samples (sealed) specifying Item numbers and Group No. alongwith the test reports in form No. 50 and name of tenderer attached to each sample. The label should comply with the Drugs & Cosmetic Act, 1940 and rules made there under with latest amendments. The quantity should be sufficient for testing purpose e.g. plastic or glass bottles; two bottles, Bulk packing of 100 tablets, one strip packing in 10x10 box. The unsuccessful tenderers are at liberty to obtain back their samples on surrendering the original copy of receipt within 45 days of finalization of the product. Thereafter such samples will be disposed of and no claim thereof will be entertained. The department is at liberty to retain the samples of successful tenderer with the office of OIPS, Nigam Bodh Ghat, Delhi till the expiry of the contract. Criteria for Evaluation of Techno-Commercial Bids – Envelop –1 Envelope no 1 should contain the following documents in the order mentioned below: 1) Earnest Money deposit 2) Downloaded tender form. 3) Sales Tax /VAT clearance certificate. 4) ITCC (Optional) and P.A.N (compulsory). 5) Valid drug license of each item quoted. (Highlight each item quoted and each page should be signed & stamped by Drug Controller) issued in Form 25D/25E in case of loan licence, Renewal on 26D/26E. 6) Performance certificate as per Performa & should clearly mention

tenderer is successfully manufacturing the drug quoted for past 3 years. 7) GMP Certificate/WHO GMP. 8) Distributor Certificate as per Annexure. 9) Certificate of Annual turn over supported by audited balance sheet and income tax return and profit and loss account for preceding three years (F.Y.) 10) Non-Conviction certificate. 11) Certificate of no black listing /debarring. 12) Details of Tenderer as per Annexure. 13) Installed Capacity as per Annexure. 14) Sample receipt as per Annexure. 15) Test report of the product from Govt. approved laboratory declaring the quoted items as of “Standard Quality” in form no 50. � Approval of Sample by the Technical board. � Any other condition preset by the Purchase board to objectively assesses the Technical Competence of the Tenderer.

Page 8 of 48

Financial Bid. Financial Bid will be re-encrypted for scrutiny, only when documents as mentioned above in Envelope No. 1 are found in order, as per requirement and the samples submitted have been approved by the Technical board. If any of the documents to be enclosed in Envelope No. 1 is not attached or is incomplete technical bid will be rejected. The price bid of technically rejected tenders/items will not be reencrypted. Note: Technically successful bid does not necessarily mean all item quoted are technically approved. � The entire financial bid shall be uploaded as per template given in the tender. � The price quoted shall be in Rupees + taxes as applicable, if any. � All prices should be quoted in Indian rupees. � All prices shall be delivery of goods at Hospital premises/FOR destination. � Prices shall remain firm and no increase will be allowed during the entire period of contract. � Rates will be revised only if Govt./State Govt. duty is imposed or changed subject to submission of documentary evidence. � Product-wise costing in respect of Drugs not covered under BICP/NPDA in Annexure VI to be uploaded (with Finance Bid).

General The authorized signatory of the firm should sign all individual pages of these terms and conditions of tender form. The signing of each page of the tender form is essential, as the tenderer has to abide by the terms and conditions of tender. The stamp of the firm should accompany the signature. Terms and conditions duly signed should be enclosed along with techno-commercial bid. Any false statement made by the tenderer will make the tender invalid and contract awarded will stand terminated. Such tenderer shall also be liable for penal action, including black listing. If the rate quoted is unreasonably low as compared to production cost, the tender for

that item is liable to be rejected. The decision of the Director Hospital Administration is final and binding. Director Hosp. Admin., Municipal Corporation of Delhi does not pledge herself/himself to accept the lowest or any tender and reserves right to split the quantity amongst the eligible tenderers and to relax any of the conditions of this tender. Director Hospital Administration reserves right to reject any or all tenders without assigning any reason/reasons. DIRECT DEMANDING OFFICER: The following officers have been declared as Direct Demanding Officers. Supplies shall be procured centrally by the D.D.Os as given below: -

Page 9 of 48

1. OIPS, Nigam Bodh Ghat, Delhi 2. R.S. Ballimaran Hospital 3. R.S. Haiderpur Hospital * If any new DDO comes in existence, the supplies will have to be made on the same terms & conditions of rate contract.

Other Terms and Conditions This tender enquiry is for executing the rate contract for medical supplies in all the Health institutions under Municipal Corporation of Delhi for the financial year 2010-11-12. 1. The tenderer should quote the exact and firm delivery period and it should not ordinarily be more than one month. 2. The offer of the tenderer must be firm. Conditional offer will not be considered. 3. Net Price/rate quoted should be FD/FOR destination in Delhi state inclusive of all taxes, duties, excise duties etc. 4. The rate quoted by the tenderer will be final and no increase will be allowed during the contract period. The rates will be revised only if any Govt./state Govt. duty is imposed or changed, and a documentary evidence of it will be required. However supply cannot be delayed on these reasons and for any such delay, penalty will be imposed. 5. All columns are to be compulsorily filled. 6. If an item is exempted of VAT/ST/CST, it should be clearly mentioned in remarks column. Agreement In the event of acceptance of contract, the agreement must be executed by the authorized signatory of the firm and Director Hospital Administration, with in 15 days of award of work order. No supply will be received before signing of contract and MCD is not liable to make payments of such supplies received before signing of the contract. The agreement shall be executed in non judicial stamp paper of Rs.100/- as per specimen at Annexure-XI. Supply Order a. After the rate contract is executed the direct demanding officers of Municipal Corporation of Delhi will place the supply orders. b. Supply orders will be placed during the contract period and will have to be accepted till the expiry of contract period. No guarantee No guarantee can be given regarding the minimum quantity of which will be drawn against this contract and the contractor will supply quantity as may be ordered by the

D.D.Os.

Page 10 of 48

Security deposit In the event of tender being accepted, tenderer will have to furnish Security deposit@ 5% of the actual value of supply orders in the form of NSC/ FDR. This should be pledged in the name of Commissioner, Municipal Corporation of Delhi. When the contract ceases the pledge will be cancelled and security will be returned to the contractor. The security shall stand forfeited in the event of breach of any of the terms of contract by the contractor. Supplies Marking and Packing o Each unit of the supply should be strictly labeled as per the requirement of Drugs and Cosmetic Act 1940 and the amendments/rules made there after. o All labels of cartons, phials, bottles, jars etc should be emboldened /imprinted/ stamped with the letters “M.C.D. Supply not for sale”. o Loose supplies, damaged packing, damaged/improper labels will not be accepted. o The packing should be able to prevent damage during transportation. o If no pack is specified tenderer may quote for standard packs available in the market. It should be ensured that only first class packing material, of uniform size for every packing is used. o The store supply should comply with the provision of the Drug and Cosmetic act, 1940 and amendments made there after. Contractor is bound to supply any minimum/maximum quantity demanded by the direct demanding officer, and part supply will be treated as non-supply. Director Hospital Administration reserves the right to reject any or all offers including the lowest quotations without assigning any reason what so ever. She/He reserves the right to split the quantity amongst the eligible tenderers and to relax any of the conditions of this Tender. Director Hospital Administration reserves the right to invite separate quotations to affect the purchases outside this contract in cases of any urgent demand. Fall Clause a. The rate quoted by the Tenderer should not be higher than the rate quoted by him to other Govt. Institutions/agencies with in Govt of NCT of Delhi during this contract period. b. If any time during the contract period, the contractor reduces the sale price, sells or offers to sell such stores, as are covered under the contract to any person/organization, including any Department of Central Govt /GNCT at a price lower than the price chargeable under the contract, he shall forthwith notify such reduction or sale or offer to sale, to MCD and the price payable under the contract for the supplies after this period will be reduced correspondingly. c. The successful bidder will be required to supply the items at the rate quoted and agreed during the extension of contract period, which will not be ordinarily more than three months. Delivery Period- Delivery period will be eight weeks from the actual date of dispatch of supply order. In case of delay in supply, a penalty @1% per wk will be imposed .The maximum penalty should not exceed 4% of total value of orders .If the contractor is not in a position to supply with in the stipulated time he will inform D.D.O. and an extension of maximum of four weeks will be granted and penalty shall be imposed during this period. Penalty for the non-supply

In case of failure to supply within eight weeks, extension can be granted for another period of four weeks on request. However, if no supply is made within 12 weeks (84) days from date of supply order, the supply order shall be cancelled subject to 4% penalty on whole amount. If there is failure to supply of an item for 3 or more occasions of a particular item, the period of contract, the firm may be debarred to supply the said item. Terms of payment The efforts will be made for making payment with in 120 days after the receipt of stores and approval of item. No interest will be paid for these. Inspections � The successful rate contract holder having the factory within or outside Delhi state must give an undertaking, when asked, before entering into the agreement, that whenever necessary the representative of MCD will be allowed to visit their factory. � The tenderer should provide all facilities and co-operation to the visiting team constituted by Director Hospital Administration for inspection of the production site / manufacturing premises. Inspection Fees Tenderer will deposit a sum of Rs. 5,000/- if the factory is located in Delhi and Rs.10, 000/- if located outside Delhi, when directed by Director Hospital Administration as inspection fee. This will be non refundable and will be deposited in the form Demand draft in favour of Commissioner M.C.D or cash deposit vide G-8 receipt. Notices All the notices intended to be served to tenderer will be deemed to have been served if sent by UPC/registered post to address mentioned in the tender.

Page 12 of 48

Quality control. a.Supply should be accompanied by the test report of the batch supplied, declaring it as of Standard Quality in form no. 50 from a Govt. approved drug laboratory. b. The test report shall in particular look into presence of steroids and heavy metals except in specified formulation of medicines. It should also indicate that the medicine is free from any fungal or extraneous contaminants. If the medicine contains precious metals like gold, silver or pearl, the quantity of percentage of such previous metal should be indicated. c. For medicines under Group II to VII (Classical) the exact formulation is available in authentic reference like A.F.I. (Ayurvedic Formulary of India) or the Ayurvedic Pharmacopoeia of India or any other recognized reference as per First Schedule of Drugs and Cosmetic Act 1940. Hence test analysis is possible for quality assurance. d. However, for patent and proprietary medicines in absence of adequate standardization of testing methods, the approval or rejection shall be on the basis of organoleptic method specifications, test reports, past performance, therapeutic efficacy, quality, past clinical experience, accompanying authentic proof of clinical trial wherever necessary and organoleptic methods that include smell, taste, grinding etc. & floating on water. e. While for approved patent/proprietary medicines under group I of Ayurvedic Medicines the manufacturing firm may be directed to submit testing protocol of the constituents/the drug that will help in better quality assurance. f. Regular and random testing of the drug will be under taken from time to time or at any

time during the shelf period from S.R.I.I.R./Govt. approved drug laboratory, at the cost of tenderer. If the tenderer fails to pay the said expenses when called upon to do so, Direct Demanding Officers of MCD have the right to recover the same from the tenderers deposits or any outstanding dues of the tenderer in MCD. g. The test report from the Govt. approved lab from where samples are tested by MCD shall be final and binding. h. In case the testing is done in more than one laboratory, the result of any one of them claiming it as substandard will be considered for appropriate action even if in other laboratory it is claimed as of standard quality. i. If a sample fails in test analysis, action should be initiated by the concerned D.D.O. against the erring firm as per guidelines of Drug Controller of India and other guidelines as stated in the subsequent pages after due process of law. The same shall however, be brought to the notice of DHO/ISM and Addl. M.H.O. (Med.). j. The supplies of all drugs that do not contain steroids or heavy metals must be accompanied by a certificate declaring that the product does not contain any steroid or heavy metal except in the form of Bhasmas. In case of Bhasmas quantity of heavy metal, precious metal and pearl, in percentage should be clearly mentioned. k. The definite storage conditions, if any, should be mentioned along with the supplies. l. For all practical purposes Shri Ram Institute of Industrial Research will be the apex Laboratory. Drugs declared, “sub standard/ not of standard quality”. As per the guidelines of Drug controller, India, the sub standard/not of standard quality drugs are A) Drugs declared misbranded, adulterated, and spurious (under rule 33E, 33EE, 33EEA of Drugs & Cosmetic Act)

Page 13 of 48

Rule – 33E of Drugs & Cosmetic Act (Misbranded drugs) – “An Ayurvedic drug shall be deemed to be misbranded – (a) if it is so coloured, coated, powdered or polished that damage is concealed or if it is made to appear of better or greater therapeutic valued than it really is; of (b) if it is not labeled in the prescribed manner; or (c) if its label or container or anything accompanying the drug bears any statement, design or device which makes any false claim for the drug or which is false or misleading in any particular. Rule – 33EE of Drugs & Cosmetic Act (Adulterated drugs): - An Ayurvedic drug shall be deemed to be adulterated – (a) if it consists, in whole or in part, of any filthy, putrid or decomposed substance; or (b) if it has been prepared, packed or stored under unsanitary conditions whereby it may have been contaminated with filth or whereby it may have been rendered injurious to healthy; or (c) if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or (d) if it bears or contains, for purposes of colouring only, a colour other than one which is prescribed; or (e) if it contains any harmful or toxic substance which may render it injurious to health; or (f) if any substance has been mixed therewith so as to reduce its quality or strength. Explanation – For the purpose of clause (a), a drug shall not be deemed to consist, in whole or in part, of any decomposed substance only by reason of the fact that such decomposed substance is the result of any natural decomposition of the drug.

Provided that such decomposition is not due to any negligence on the part of the manufacturer of the drug or the dealer thereof and that it does not render the drug injurious to health. Rule – 33EEA of Drugs & Cosmetic Act (Spurious drugs): - An Ayurvedic drug shall be deemed to be spurious – (a) if it is sold, or offered or exhibited for sale, under a name which belongs to another drug; or (b) if it is an imitation of, or is a substitute for, another drug or resembles another drug in a manner likely to deceive, or bears upon it or upon its label or container the name of another drug, unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug; or (c) if the label or container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist; or (d) if it has been substituted wholly or in part by any other drug or substance; or (e) if it purports to be the product of a manufacturer of whom it is not truly a product. Actions � In all above cases the contract for the particular item with the firm shall be cancelled & purchase cost of full order irrespective of the amount consumed shall be recovered from the contractor from his deposit or from his any pending bill in M.C.D. � The unconsumed quantity of the supply will be destroyed in presence of Drug Controller and any expenditure incurred on this will be recovered from contractor. � The firm shall be black listed for the current and next contract period.

Page 14 of 48

� Drug Controller to be informed for taking necessary action. B) Drug declared not of standard quality are further classified, as per classification of Drug Controller General of India. Action will be taken accordingly. a) Minor defect b) Major defect Actions � Minor defect o Replacement of existing stock. o Forfeiture the security deposit for the supply, from the bills /other pending dues/ deposits in MCD. o Deduction of Lab Testing Charges. o Inform Drug Controller. o All subsequent supplies of the firm shall be subjected to test analysis. � Major Defect o The supplier should lift the existing stock. o No payment of the supply including consumed stock and such amount may be deducted from bills /other pending dues/ deposits in MCD. o The firm will be debarred for that item for the remaining period of the contract and for the next contract period. o Forfeiture of security. o Deduction of Lab Test charges. o Inform Drug Controller. o All subsequent supplies of the firm shall be subjected to test analysis. Shelf life The maximum time period permitted between the date of manufacturing and the date of supply of drug shall not be more then ¼ of the whole life period of such drug.

Final Packing � Final Packing shall be done in corrugated fiber boxes conforming to IS1503 & supplementary schedule number CIGS 121. These shall be suitable and strong enough to bear transit hazards. � Glass bottles used should be certified as USO Type-I / Type-II. � In case of plastic container evidence of being, “biological test plastic”. � The other conditions of packing and labeling should be strictly as per norms laid down under Rule-161 of Drugs & Cosmetic Act 1940. The same has been enclosed as Annexure-IX. � Goods should be dispatched at carrier’s risk failing which they should properly be covered by transit insurance or Government insurance. However, the supplier will be responsible until the entire store contracted is in good condition at destination points. The actual quantity of different items which may be required to be supplied for purchase under this tender shall be informed by the respective Direct Demanding Officer (DDO) situated in Delhi, Municipal

Page 15 of 48

Corporation of Delhi, limits, from time to time as per their requirements during the tenure of the tender. Certificate on Bill/ Challan Every challan should bear the following certificate: - The product supplied under this bill/ challan is manufactured as per standards mentioned in Pharmacopoeia/ ISI standard and the product is of standard quality. We are solely responsible for the defect/deviation from these standards, if found any time in future. Certified that item supplied has not been debarred or firm is not blacklisted. Procedure of supplies and risk purchase The DDO mentioned in the schedule will send the order for Drug/ Medicines by registered post or by self to the tenderer. The rate contract holder should acknowledge the receipt of the order to the DDO by letter sent by registered post A/D within 15 days, stating the exact delivery period required and quantities he will be supplying to the DDO if the rate contract holder is not in a position to supply the entire quantity intended, he will inform the DDO and also communicate the same to the D.H.O. (Ayurveda)/D.D.O. by letter under registered post. If the rate contract holder fails to supply the stores within the stipulated delivery period, penalty at the rate of 1% of the cost of ordered quantity, per week or part thereof supplied later by him or maximum penalty up to 4% of the total value of supply order, supplied late by him, will be charged by concerned DDO and deducted from the Bills or security deposits after confirmation from Director Hospital administration MCD. An extension maximum of four weeks will be granted and penalty shall be imposed upon during that period. In the event the firm has failed to supply within 84 days the supply order shall automatically stand cancelled, and penalty of 4% on the whole amount of supply order shall be deducted from other unpaid dues, security money/E.M. Arbitration Decision of the Director Hospital Administration of Municipal Corporation of Delhi is final .All the disputes related to Rate contract shall be subject to the territorial jurisdiction of Delhi Courts. Other Conditions No assistance in obtaining import license or any license/permit etc. in respect of raw material on finished goods of accepted items will be provided by MCD. In case of items or drugs, not manufactured in India, the tenderer will have to import directly & if any re packing is required, repacking work will have to be got done at their own cost.

In case the quantity mentioned in the tender for stated under heading approximate annual requirement are only approximate estimate/quantity and the Director Hospital Administration is not bound to purchase the same quantities. The Director Hospital Administration also reserves the right to increase or decrease these quantities as per requirement during the tenure of tender. .

Page 16 of 48

Tenderer must distinctly understand that they will not be allowed any increase over the rates quoted by them during the contract period. The rate revision may be considered only in case of imposition of duty or increase in tax by Govt., either Central or State and only after necessary legal documentary evidence is produced by the firm in support thereof. However, no supply of drugs shall be stopped because of this reason during the contract period and if supply is stopped, the tenderer will be liable for risk purchase and penalty there under. The successful tenderer will be required to supply the items at the rate quoted and agreed during the extension of contract period, which will not be ordinarily more than three months beyond the contract period. The supplier shall arrange free replacement of any quantity, which may deteriorate in potency, strength etc before date of expiry marked on labels. In case of controlled goods by the Govt., the quotation must be sent subject to the controlled rates and other conditions and contractor will be paid at the controlled price or rates offered by the contractor which ever is less. Any dues or payment arise from the contract from contractor toward M.C.D., where no specific time is laid down in terms and conditions will be paid by the contractor with in a limit communicated to him. The past performance of the contractor will be taken into consideration for award of rate contract. The tenderer should submit an affidavit on stamp paper stating that the drugs, which are being quoted, are not banned under section 26(A) of Drug and cosmetic Act. Director Hospital Administration Municipal Corporation of Delhi. Contractor _________________________ _________________________ Witness: 1) _________________________ Name and address: 2) _________________________ Name and address:

Page 17 of 48

Forwarding letter of the firm Annexure-1 From To Director Hospital Administration Municipal Corporation of Delhi Town Hall, Chandni Chowk,

Delhi- 110 006. Subject: Supply of Drugs at the quoted rate to Municipal Corporation of Delhi, Health Department for the period of 2 years i.e. 2008-09-10. Sir, I/We/am/are authorized signatories of M/s ____________________________ _____________ ___________________________________________________________________________________ _______ I/we hereby undertake as follows: - 1. I/we hereby undertake to supply drugs in areas specified by the Director Hospital Administration, Municipal Corporation of Delhi for the period of two years at the rates quoted by me/us and in the packing specified in the prescribed tender form, which is submitted herewith according to the instructions and the terms and conditions. The duration of the said contract may be extended for a period of three months if the Director Hospital Administration so desires. 2. The rates quoted against each item of drug by me/us in the tender are inclusive of all taxes, packing, freight charges and duties payable during the contract period. Insurance of the goods, whenever required will be done with the Government insurance agency. 3. Necessary documents as required are enclosed herewith in the order in which they are mentioned. 4. Samples of the drugs quoted are submitted on or before due date in suitable sealed packing. 5. I/we understand that security deposit submitted on entering in to contract, is likely to be forfeited in the event of lapse on my/our part to comply with the terms and conditions of the tender and also on the supplying drugs/ items of sub standard quality or if proven to have followed unscrupulous practices apart from the liability of penal action for violating the law of the land.

Page 18 of 48

6. I/we have carefully read and understood the terms and condition to avoid any error, omission. I/we shall abide by these conditions. I/we will follow them very scrupulously. 7. I/we also take cognizance of the fact that failure to furnish the information called for by the Director hospital Administration, Municipal Corporation of Delhi or to comply with any requirements laid down under the conditions will be considered as disqualification and the tender by rejection on that account. 8. I/we undertake to abide by the instructions issued by the Director Hospital Administration, Municipal Corporation of Delhi from time to time. 9. I/we undertake to bear the cost of Bio availability testing/ testing for the quality of the product supplied whenever the Director Hospital Administration, Municipal Corporation of Delhi or any other authority acting on their behalf decides to do this testing during the contract period. 10. In case of my supply declared substandard by any approved agency I/we am/ are liable for appropriate action including debarring/blacklisting. 11. The rate quoted by me/us will not be higher than the rate quoted by me/us to any Govt. Institution/agency with in Govt. of NCT of Delhi during the contract period. 12. If at any time during the execution of the contract, I/we reduce the sale price or sells or offers to sell such stores, as are covered under the contract, to any person/ organization, including any Dept of the Central Govt/ GNCTD at a price lower than the price chargeable under the contract, I/we shall forthwith notify such reduction or sale or offer of sale to MCD, and the price payable under the contract for the store supplied after the date of coming into force of such deduction or sale or offer shall stand correspondingly reduced.

I/we hereby undertake to abide by the terms and conditions of the contract modified from time to time and I/we have signed all the papers of terms and conditions and filled up prescribed Performa’s given along with the tender. Yours faithfully, (Signature of tenderer with stamp) (Authorized Signatory)

Page 19 of 48

ANNEXURE-II FOOD AND DRUG ADMINISTRATION No. Office of the Drug Licensing Authority ------------------------------------------- ------------------------------ Division ------------------------------------------- Dated ____________________ PERFORMANCE CERTIFICATE This is to certify that Messrs ________________________________________________ __________________ ______________________________________ having manufacturing premises at ___ __________________ __________________________________ is holding license(s) valid up to _____________ __________________ ________________________ informs ____________________________ No. __________________ under the Drugs and Cosmetics Act, 1940, and rules thereunder, on the said address and that the performance of the aforesaid manufacturer for the preceding three (3) years is satisfactory, and that -- i. The drugs in respect of which this certificate is issued is/ are manufactured on the own license of the manufacturer and not on the loan license. ii. The manufacturer has his own quality control section. iii. During the preceding three (3) years there is no instance of suspension or cancellation of a part of a license issued to the manufacturer, in respect of any of the drugs which are offered by the manufacturer in the tender mentioned in para (2) below, on account of the drug under tender being not of standard quality. iv. During the preceding three (3) years there is no instance of suspension or cancellation of the factory license (full license) on any account. v. There is no instance wherein any of the drugs manufactured by the manufacturer is reported to be spurious or adulterated. vi. No administrative action or prosecution is contemplated or launched against the manufacturer under the Drugs and Cosmetics Act, 1940 and rules thereunder in respect of any of the Drugs offered by him in the tender mentioned in paragraph (2) below. vii. During the period of three (3) preceding years the manufacturer has not been convicted under the Drugs and Cosmetics Act, 1940 and rules thereunder, to undergo imprisonment for more than one day.

viii. The manufacturer has submitted year wise (April to March) 3 years statement of production and sale of the concerned drugs duly certified by Chartered accountant. 2. This certificate is issued for the purpose of _____________________________________________________ _______________________ Tender for the contract in respect of the drugs mentioned below:- Name of the drugs manufactured under _____________________________________________________________ (1) (2) Signature/Seal of Drug Licensing Authority. Page 20 of 34

ANNEXURE-III

AUTHORITY LETTER (Authority letter to be issued by the manufacturer for appointing Distributor/Dealer/Agent etc). I/we the undersigned who is/are authorized signatory/signatories of the manufacturing firm M/s_______________________________________________________________________________ _______ Address___________________________________________________________________________ ______ _____________________________________________________________________________ do hereby Authorize M/s ________________________________________________________________________ Address ____________________________________________________________________________ to supplying items/drugs/collect the orders/raise the bills for the items manufactured by me/us under the tender published in the Government Gazette No. _______________________ dated ____________ I/we have not authorized any other distributor/agents/Dealer etc for this purpose. I/we have gone through all the terms and conditions of the tender and will be binding on me/us and also on the Distributor/Dealers/Agent M/s ________________________________________________ appointed by me/us during the whole contract period including extension period of the said contract. I/We hereby undertake that I/we shall not change our authorized distributor/agent/dealer as mentioned during the period of contract including extension period. Authorized Signatory of the firm (Rubber stamp)

Page 21 of 48

ANNEXURE IV

(This is to be issued on firm’s approved letterhead)

SAMPLE RECEIPT DRUGS etc. (To be submitted in triplicate) TENDER FORM NO………… …... Please receive following samples of Drugs/ Surgical item from M/s __________________________ ________________________________________________ Address _________________________ ________________________________ for the tender enquiry No. ________________________ dated ___________. (1) Serial No. of Tender form ____________________________________________ (2) Schedule No.______________________________________________________ (3) Item No.__________________________________________________________ (4) Name of Drug/medicine.___________________________________________ (5) Batch No._________________________________________________________ (6) Total No. of units submitted __________________________________________ (7) Manufacturing Date _________________________________________________ (8) Manufacturing License No. ___________________________________________ (9) Expiry Date _______________________________________________________ (10) Specific storage condition ____________________________________________ (11) Type of container used. ______________________________________________ (12) Remarks _________________________________________________________ Place : Tenderer's Signature and stamp Date : Seal : Received above samples Receiver's signature and date and Stamp

Page 22 of 48

ANNEXURE V

PROFORMA FOR QUALITY CONTROL Name and address of Tenderer _____________________________ _____________________________ _____________________________ (i) Company's standing and experience of formulation : (a) Year of establishment of the firm ______________________ (b) Year of introduction of the product _____________________

(ii) Information of the product: (a) Description of the product (b) Tests: 1. Dissolution and disintegration. 2. Composition. (iii) Quality control facilities within the manufacturing unit : ______________________________________________________ ______________________________________________________ (iv) Raw material: Basic Manufacturer: Yes/ No. If no, source of the raw material: (v) I/we undertake to bear the cost of Bio-availability testing/testing for the quality of the product whenever the Director Hospital Administration, MCD, or any other authority acting on their behalf decides to this testing. Signature and stamp of Tenderer.

Page 23 of 48

ANNEXURE VI (Optional) (To be uploaded with Financial Bid) PRODUCT WISE COSTING IN RESPECT OF DRUGS NOT COVERED UNDER BICP/National Pharmaceutical Pricing Authority or DPCO

PROFORMA TO BE ENCLOSED IN ENVELOPE NO. 2 Name of tenderer ________________________________________________ Name of Drug ________________________________________________ Schedule No. ________________________________________________ Item No. ________________________________________________ Strength of product ________________________ Weight _________________ Batch No. ________________________ Pack size ________________ Name of the raw material_________________________________________________ Quantity ________________________ Rate ____________________ Unit ________________________ Amount __________________ Cost of raw material/per batch Rs.___________________________ Add losses % Rs.___________________________ Total cost of raw material per batch Rs.___________________________ Raw material cost per pack Rs___________________________ Name of raw material __________________________________________________ Quantity _____________________ Rate ______________________ Unit ____________________________________________amount___________________ Cost of raw material per batch :Rs___________________________ Add losses % :Rs.___________________________ Total cost of packing material per batch :Rs.___________________________ SUMMARY Raw material Price Conversion cost Packing material Price rounded to Packing charges Actual cost Mark up Excise duty Taxes, if any Signature and stamp of tenderer

Page 24 of 48

ANNEXURE VII PROFORMA TO BE SUBMITTED ALONGWITH TENDER (In Envelope No. 1) (To be submitted in duplicate for award of contract of drugs and medicine for Health Institutions under Municipal Corporation of Delhi). Statement of particulars of Drug Manufacturers/ Distributors etc. (Put a tick mark where applicable, write "N.A" where not applicable). 1. Name and address of the firm: (a) Places of manufacture (In case of firms having more than one place, Mention the nearest). (b) Registered Head Office, Postal address and (c) Delhi Office address with Phone No. (if any). (d) Total Annual Sales Turnover in the last financial year. 2. (a) Is the firm registered under the Indian Companies act, 1913, Companies Act I of 1956 or any other act in force, if so, furnish certified Photostat copies of certificate of registration. (b) In case of limited companies, furnish a copy of the Memorandum of Articles of Association. (c) In case of proprietorship/partnership firms name of Proprietor/Partners/Directors with addresses (Two in order of % of share). 3. Ownership status of the firm (Delhi Govt/other State Govt/ Central Govt. / Joint sector/ Co-operative/SSI). 4. Whether tendering as a Manufacturer etc. (State your category) 5. Name/Post of the Officer, address & Phone No. Who should be contacted by this office in case of any urgent problem. 6. Location of other drug manufacturing works/factory/factories Owned by the firm (if any). 7. (a) Details of arrangements for quality control. (b) Whole time analytical chemists with names, qualifications and residential address of two of them. (c) Equipment for quality control (Given name of the important equipments as relevant to Ayurvedic Medicines) 8. In case of manufacturing units: (i) Total number of whole time chemists (Manufacturing /production/analysis/Quality control) (ii) Whether covered by ESI, if so state number of registration. (iii) Are you registered under Factory Act? 9. Specify how much quantity of products were supplied to the Municipal corporation of Delhi in the last four tender years as shown below (use separate sheet, if necessary, 2004 to 2007 including extension period): -

Page 25 of 48 Tender year Name of the drug with CSPOESIS Cat No. Percentage of share allocation Quantity of order received with date Quantity of supply Amount of business in Rs. Name of stores/institute to whom supply is made 10. Please check and state whether you have submitted the following: - a. Forwarding letter-- Annexure No. I Enclosed/not enclosed b. Earnest Money Deposit, DD No. & Date. Enclosed/not enclosed c. Income Tax Clearance Certificate (Optional)/PAN Enclosed/not enclosed d. Sales Tax Clearance Certificate./VAT clearance. Enclosed/not enclosed e. Drug License with order of endorsement of each drug. Enclosed/not enclosed f. Performance Certificate-- Annexure No. II Enclosed/not enclosed g. GMP Certificate Enclosed/not enclosed h. Bonafide Distributor Certificate-- Annexure No. III Enclosed/not enclosed i. Certificate of Annual Turn over Enclosed/not enclosed j. Sample Receipt (Duplicate) --- Annexure No IV Enclosed/not enclosed Certificate of USO Type (Req/Not Req) Enclosed/not enclosed Certificate of Biological Test (Req. /Not req) Enclosed/not enclosed Lab report for Inj. And surgical items (Req/Not req) Enclosed/not enclosed Sterility test report (Req/Not req) Enclosed/not enclosed k. Registration Certificate D.G.S & D, NSSIC, Rlys., Defence, DDG (Store) etc. Enclosed/not enclosed l. Performa for Bio availability Data (if applicable)-- Annexure No. Enclosed/not enclosed m. Performa (Quality control) as per-- Annexure No. V Enclosed/not enclosed n. Detail of tenderer in Annexure-VII. Enclosed/not enclosed. o. Installed capacity --Annexure No. VIII Enclosed/not enclosed p. Do you manufacture any product on "Loan License basis Enclosed/not enclosed Give details from where you are getting it manufactured. Page 26 of 34 Detailed list and addresses of firms. q. Are you manufacturing products for other firms on "Loan Enclosed/not enclosed License basis"; if so details of name of the firms, number, Names of products manufactured and % utilization of plan and capacity to be given. r. Is the firm in technical collaboration with any foreign Enclosed/not enclosed Manufacturer, if so details thereof. I/we hereby declare that particulars furnished above are true to the best of my/our knowledge and belief that if any of the particulars is found to be materially incorrect/misleading my/our tender shall be liable to be rejected and I/we are liable for penal action as per term specified in the "terms and conditions of tender". Date Full signature of the Tenderer With official seal and address.

Page 27 of 48

ANNEXURE VIII

INSTALLED CAPACITY OF THE FIRM Name of tenderer_________________________________________________________ _________________________________________________________ Address _________________________________________________________ _________________________________________________________ A statement showing installed capacity of each quoted item per year with existing plant and machinery and quantity, which we will be able to supply. ______________________________________________________________________________ Sr. No. Group Items Installed Quantity offered Capacity for supply _______________________________________________________________________ I. CAPSULES II. OINTMENT III. TABLETS IV. PHIALS V. SYRUP BOTTLES VI. OTHER Signature of tenderer and stamp. Note – Strike out whichever is not applicable.

Page 28 of 48

ANNEXURE IX

(LABELLING, PACKING AND LIMIT OF ALCOHOL IN) AYURVEDIC (INCLUDING SIDDHA) OR UNANI DRUGS (1) There shall be conspicuously displayed on the label of the container or package of an Ayurvedic 9 including Siddha) or Unani drug, the true list of all the ingredients used in the manufacture of the preparation together with the quantity of each of the ingredients incorporated therein and a reference to the method of preparation thereof as detailed in the standard text and Adikarana, as are prescribed in the authoritative books specified in the First Schedule of the Act. Provided that if the list of ingredients contained in the medicine is large and cannot be accommodated on the label, the same may be printed separately and enclosed with the packing and reference be made to this effect on the label. (2) The container of a medicine for internal use made up ready for the treatment of human ailments shall, if it is made up from a substance specified in Schedule E 1) , be labeled conspicuously with the words Caution : to be taken under medical supervision both in English and Hindu Languages. (3) Subject to the other provisions of these rules, the following particulars shall be either printed or written in indelible ink and shall appear in a conspicuous manner on the label of the innermost container of any Ayurvedic (including Siddha) or Unani drug and on any other covering in which the container is packed, namely: (i) The name of the drug. For this purpose the name shall be the same as mentioned in

the authoritative books including in the First Schedule of the Act. (ii) A correct statement of the net content in terms of weight, measure or number as the case may be. The weight and volume shall be expressed in metric system. (iii) The name and address of the manufacturer. (iv) The number of the licence under which the drug is manufactured, the figure representing the manufacturing licence number being preceded by the words ‘ Manufacturing Licence Number’ or ‘Mfg. Lic.No.’ or “M.L.”. (v) A distinctive batch number, that is to say, the number by reference to which details of manufacture of the particular batch from which the substance in the container is taken are recorded and are available for inspection, the figure representing the batch number being preceded by the words ‘ Batch No.” or “ Batch” or “ Lot Number” or “Lot No.” (vi) The date of manufacture. For this purpose the date of manufacture shall be the date of completion of the final products, or the date of bottling or packing for issue. (vii) The words “ Ayurvedic medicine” or “ Siddha Medicine” or “ Unani medicine” as the case may be. (viii) The words “FOR EXTERNAL USE ONLY” if the medicine is for external application. (ix) Every drugs intended for distribution tot eh medical profession as a free sample shall, while complying with the labelling provisions under clauses (i) or (viii), further bear on the label of the container the words “Physician’s sample. Not to be sold” which shall be overprinted. (x) (a) Preparation (Asavas) with high content of alcohol as base

Page 29 of 48

________________________________________________________ Name of the drug Maximum size of packing (i) Kapur Asava 15ml. (ii) Ahiphenasava 15ml. (iii) Margamadasava 15ml. (b) Preparations containing self-generated alcohol. _________________________________________________________ Name of the drug Maximum content of Maximum Alcohol (Ethylalcohol v/v) size of Packing (i) Mritsanjivani Sura 16 percent 30ml. (ii) Mahadrakashava 16 percent 120ml.) _________________________________________________________ (4) Nothing in these rules shall be deemed to require the labelling of any transparent cover or of any wrapper-case or other covering used solely for the purpose of packing, transport in delivery.

Page 30 of 48

ANNEXURE X

(FORM 50) (See Rule 160 D (f) Report of test or analysis by approved Laboratory Report of test or analysis by approved Laboratory 1) Name of manufacturer whom sample received together with his manufacturing license number

under the Act or the rules made thereunder:……………… 2) Reference number and date of the letter from the manufacturer under which the same was forwarded:……………………………………………………………….. 3) Date of receipt of the sample: …………………………………………………… 4) Name of Ayurvedic, Siddha and Unani drug of raw material purporting to be contained in the sample:……………………………………………………………. 5) Details of raw material of final product (in bilk finished pack)*as obtained from the manufacturer: a) Original manufacturer’s name in the case of raw materials and drugs repacked ……… …………………………………………………….. b) Batch number………………………………………………………… c) Batch size as represented by sample ………………………………… d) Date of manufacture, if any …………………………………………. e) Date of Expiry, if any ……………………………………………….. 6) Results of test or analysis with protocols of test or analysis applied or as per Ayurvedic, Siddha or Unani Pharmacopoeial standards. 7) Other specific tests for identity, purity, quality and strength of patent and proprietary drugs. In the opinion of the undersigned, the sample referred to above is of standard quality/ is not of standards quality as defined in the Act or the rules made there under for the reason given below: - ………………………………………………………………………………………….. Dated (Signature of the Person- in –charge of testing) Place (F.No………………………………………….) Name &Designation & Seal Name & Address if the Laboratory……………. …………………………………………………. …………………………………………………. Licence No……………………………………… Note: Final Product includes repacked material Delete whichever is not applicable

Page 31 of 48

Annexure-XI

AGREEMENT

This agreement is made on ________ day of _______________ between Municipal Corporation Of Delhi through Director Hospital Administration hereafter called the Corporation as first party and……………………… ……………… ………………………………………………..........here after called the contractor as second party. Contractor here by agrees to the following terms and conditions 1. After the acceptance of rate and agency by Director Hospital Administration, Direct Demanding officers will place the orders and contractor will supply them at any place mentioned in the supply order with in municipal limits of Delhi. 2. Security deposit-In the event of tender being accepted, tenderer will have to furnish Security deposit@ 5% of the estimated value of supply orders in the form of NSC/ FDR. This should be pledged in the name of Commissioner, Municipal Corporation of Delhi. 3. When the contract ceases the pledge will be cancelled and security will be returned to the contractor. The security shall stand forfeited in the event of breach of any of the terms of contract by the contractor.

4. No guarantee can be given regarding the minimum quantity, which will be drawn against this contract but the contractor will supply quantity as may be ordered by the D.D.O.s . 5. The supply will be accepted only if it is accompanied by Test report from Govt approved drug laboratory, in form 50,claiming it as of standard quality. 6. The supply is subject to the approval by person /board as authorized by Director Hospital Administration, who will have right to reject if it is not in accordance with the sample and other specifications. 7. Delivery Period-The order has to be executed with in eight week of dispatch of supply order dispatched by registered post. In case contractor fails to execute it with in stipulated time penalty @ of 1% per week will be imposed up to a maximum of 4%. Delivery period may be extended with prior approval of Director Hospital Administration up to a maximum period of 4 weeks, which will be permissible for extension. Penalty shall be imposed during this period. 8. The contractor shall ensure that the store ordered complies to the provision of Drug& Cosmetic Act 1940 and rules made there after and are as per the specification given in the tender. 9. Non supply-If the articles are not supplied by the scheduled date, as above, full or in part, the order in respect of the quantity not supplied is liable to be cancelled at the contractor’s risk and expense. The extra expenditure thus incurred in procuring the supplies from elsewhere will be recoverable from contractor at the discretion of D.D.O. The recovery will be made from any of his bill pending in M.C.D. or earnest money and security deposits. i. After 84 days the supply order shall automatically cancelled and penalty of 4% on whole amount shall bededucted from unpaid dues. ii. Two or more instance of non-supply for a particular item by a firm will render the firm liable to be debarred to supply the item. 10. Arbitration-All disputes relating to rate contract shall be subject to the territorial jurisdiction of Delhi Courts 11. Quality Control-The D.D.O reserves the right for getting sample tested regularly and randomly from anyapproved drug laboratory at the cost of contractor. The report has to be accepted by the firm. The report of the lab shall be final and binding. 12. Furnishing of wrong information and false documents will make contractor liable to be debarred / blacklisted from participating in Municipal rate contract, even detected at a later date.

Page 32 of 48 13. If any supply supplied against the rate contract is declared “Not of Standard quality”, on test analysis from any Govt. approved Laboratory, the contractor will be liable to replace the entire quantity or make full payment irrespective of the fact that a part or whole of the supply is consumed. Depending on the severity firm is liable to be de-barred for the current & next two years for that item or any other punitive action as per existing guidelines. 14. Fall Clause-The rate quoted by the Tenderer should not be higher than the rate quoted by him to other Govt.Institutions/agencies with in Govt of NCT of Delhi during this contract period. 15. If any time during the contract period, the contractor reduces the sale price, sells or offers to sell such stores ,as are covered under the contract to any person/organization, including any Department of Central Govt /GNCT at a price lower than the price chargeable under the contract, he shall forthwith notify such reduction or sale or offer to sale , to MCD and the price payable under the contract for the supplies after this period will be reduced correspondingly. 16. Shelf life-The maximum time period permitted between the date of manufacturing the and date of supply of drug shall not be more then 1/4 of the whole life period of such drug. 17. If the contractor commits, default of any of the terms and conditions of the agreement the corporation may in spite of previous waiver and in spite of any penalty imposed on the contractor, forfeit the whole or a part of security, deposited by the contractor for the unsatisfactory performance of the terms and conditions of the agreement. The decision of the Director Hospital Administration shall be final and binding with the contractor. 18. The drug for which rate has been quoted is not banned under section 26 (A) of drug and cosmetic Act.

Contractor Director Hospital Administration Witness: - 1. ______________________________ ______________________________ 2. ______________________________ ______________________________ Witness: - 1. ______________________________ ______________________________ 2. ______________________________ ______________________________

Page 33 of 48

MUNICIPAL CORPORATION OF DELHI

(HEALTH DEPARTMENT) SCHEDULE OF EVENTS

S. No.

Tender No.

Date of sale of Tender w.e.f. (As per schedule in website).

Purchase & Down load of Tender Documant

Online Bid Preparation & Hash submission

Technical & Financial lock

Re-encryption of on line bid

Last date for submission ofsamples

Manual Technical Bid opening

1.

2.

3.

4.

5.

6.

7.

� Tender Forms can be down loaded from Website of MCD i.e. http://mcdetenders.com. � Techno-commercial-bid will not be received after the date and time as per above. � In case of date of submission/opening of tender is declared a holiday, tenders will be received/opened on the next working day at the same time and place. � Eligible/interested bidders can obtain further information from the office of OIPS, Nigam Bodh Ghat, Delhi on any working day during office hours. Deputy Health Officer (Ayurveda), M.C.D. Pry. School Bldg., More Sarai, (Near Lajpat Rai Mkt.), Delhi-110006.

DETAILS OF MEDICINES UNDER GROUP –VII

(PANCHKARMA TREATMENT MEDICINE)

DRUGS USED IN “BASTI KARMA”

S.NO. NAME OF THE MEDICINE/ DRUG PACKING REF. BOOK, IF

ANY 1. TIL TAIL 450ML A.F.I. 2. JATYADI OIL ” ” 3. NIRGUNDI OIL ” ” 4. NEEM TAIL ” ” 5. TEJ PHAL 1 KG. NONE 6. LAVANG ” ” 7. PIPLAMOOL ” ” 8. CHAVAYA ” ” 9. CHITRAK ” ” 10. NAGARMOTHA ” ” 11. METHI ” ” 12.. KALA JEERA ” ” 13. AJWAIN ” ” 14. PALASH PUSHP ” ” 15. MADHU ” ” 16. SHIRISH ” ” 17. SAHANJANA ” ” 18. MAHAMANJISHTHADI KWATH ” A.F.I. 19. MAHAMANJISHTHADI KWATH BRAHAT ” ” 20. PANCHKALLAV KWATH ” ” 21. PUNARNAWA KAWATH ” ” 22. VARUNADI KAWATH ” ” 23. NIMBADI KAWATH ” ” 24. DASHMOOL KAWATH ” ” 25. RASNADI KAWATH ” ” 26. ERAND PATRA ” ” 27. NEEM PATRA ” ” 28. KATELI PANCHANG ” ” 29. AMRATA (GILOY) ” ” 30. ARABVADH PATRA (AMALTAS) ” ” 31. DARU HALDI ” ” 32. AMA HALDI ” ” 33. SAINDHAV LAVAN ” ” 34. HARAD ” ”

35. BAHEDA ” ” 36. AMLA ” ” 37. SONTH ” ”

Contd.next page

DETAILS OF MEDICINES UNDER GROUP –VII

DRUGS USED IN VIRECHAN

S.NO. NAME OF THE MEDICINE PACKING REF. BOOK, IF

ANY 1. TRIVART (NISHOTH) 1 Kg. NONE 2. KUTKI ” ” 3. AMALTAS GOODA ” ” 4. ERAND BEEJ TEL ” ” 5. SANAI PATTI ” ” 6. MAROD PHALI ” ” 7. KAMPEELAK ( KAMEELA) ” ” 8. ICHABHEDI RAS ” ” 9. JALODRADI RAS ” ” 10 PATOLADI KAWATH ” ” 11. PHALTRIKADI KWATH ” ”

DRUGS USED IN VAMAN

1. MADANPHAL 1 Kg. NONE 2. KARANJ ” ” 3. REETHA ( ARISHT) ” ” 4. INDRAYAN ” ” 5. MADHUYASHTI ” ” 6. VACHA ” ” 7. VIDANG ” ”

OILS USED IN PANCHKARMA THERAPY

1. BALA ASHWAGHDHADI LAKSHADI TEL 1 Ltr. A.F.I. 2. CHANDANBALA TEL ” ” 3. DHANVANTRI TEL SADA ” ” 4. DHANVANTRI TEL SHATPAKI ” ” 5. KSHEERBALA TEL SADA ” ” 6. KSHEERBALA TEL SATPAKI ” ” 7. LAKSHADI TEL ” ” 8. MAHABALA TEL ” ” 9. MAHAMASH TEL ” ” 10. MAHANARAYAN TEL ( KESAR YUKT) ” ” 11. PANCHGUN TEL ” ” 12. PIND TEL ” ” 13. PARSARNI TEL ” ” 14. RASNADI TEL ” ”

15. SAINDHAWADI TEL ” ” Contd. Next page

DETAILS OF MEDICINES UNDER GROUP –VII

DRUGS USED IN “NASYA”

S.NO. NAME OF THE MEDICINE PACKING REF. BOOK, IF

ANY 1. ANU TEL 1 Ltr. A.F.I. 2. KATFALADI NASYA 1kg ” 3 SHAD BINDU TEL ” ”

GHRIT USED IN SNEHAN

1. BRAHMI GHRIT 100GMS A.F.I. 2. MAHATRIFLA GHRIT ” ” 3. MAHATIKT GHRIT ” ” 4. PANCHTIKT GHRIT ” ” 5. PANCHTIKT GOOGAL GHRIT ” ” 6. SARASWAT GHRIT ” ” 7. SHATAVARI GHRIT ” ” 8. TRIFLA GHRIT ” ”

NB:- 1. All the tablets/capsules shall be in blister packing of 10x10 quantity as

mentioned in the respective group against each. No packing of loose tablets/

capsules shall be accepted.